Rezultati - Jean‐Jacques Dutheil
- Showing 1 - 2 results of 2
-
1
Average Adherence to Boosted Protease Inhibitor Therapy, rather than the Pattern of Missed Doses, as a Predictor of HIV RNA Replication od Jean‐Jacques Parienti, Kathleen Ragland, F. Lucht, Arnaud de La Blanchardière, S. Dargère, Yazdan Yazdanpanah, Jean‐Jacques Dutheil, Philippe Van de Perre, Renaud Verdon, David R. Bangsberg
Izdano 2010Artigo -
2
Forgiveness of Dolutegravir-Based Triple Therapy Compared With Older Antiretroviral Regimens: A Prospective Multicenter Cohort of Adherence Patterns and HIV-RNA Replication od Jean‐Jacques Parienti, Anna Fournier, L. Cotte, Marie-Paule Schneider, Manuel Etienne, Guillemette Unal, Philippe Van de Perre, Jean‐Jacques Dutheil, Elodie Morilland-Lecoq, Fabien Chaillot, David R. Bangsberg, Amandine Gagneux‐Brunon, Thiérry Prazuck, Matthias Cavassini, Renaud Verdon, Laurent Hocqueloux
Izdano 2021Artigo
Iskalna orodja:
Sorodne teme
Antiretroviral therapy
Cohort
Internal medicine
Medicine
Oncology
Viral load
Virology
Biochemistry
Biology
Cohort study
Confounding
Dolutegravir
Enzyme
Gene
Human immunodeficiency virus (HIV)
Logistic regression
Odds ratio
Pharmacology
Prospective cohort study
Protease
Protease inhibitor (pharmacology)
RNA
Raltegravir
Regimen
Replication (statistics)
Reverse transcriptase
Reverse-transcriptase inhibitor
Ritonavir
Viral replication
Virus